Dhaliwal Harpreet S. 4
4 · Vaxcyte, Inc. · Filed Feb 1, 2022
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Dhaliwal Harpreet S.
Chief Technical Ops Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-11-08+100,000→ 100,000 totalExercise: $25.06Exp: 2031-11-07→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]1/4 of the shares subject to the option shall vest on October 1, 2022, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date